Intellipharmaceutics International (IPCIF) 20-F 2017 FY Annual report (foreign)

EXHIBIT 4.80

Extension of Debenture Maturity Date

To:                

lntellipharmaceutics International Inc. (the “Company”)

Re: 

Debenture dated January 10, 2013, with an original face amount of US$1,500,000 issued by the Company to Dr. Isa Odidi and Dr. Amina Odidi (the “Debenture”) and the Maturity Date (as defined in the Debenture) of such Debenture

The undersigned hereby agree that the Maturity Date of the Debenture (currently October 1, 2017) is extended to October 1, 2018.

DATED as of September 28, 2017

/s/ Amina Odidi                                                    /s/ Isa Odidi

Amina Odidi                                                          Isa Odidi

  Accepted and agreed to this 28th day of September, 2017

Intellipharmaceutics International Inc.

  By: /s/ Michael Campbell

  Name: Michael Campbell

  Position: Corporate Secretary